Ultimately, a combined strategy—integrating biological interventions like GH treatment (for early weight management) and behavioral approaches (like psychotherapeutic support)—is essential for effectively and sustainably addressing hyperphagia and body weight in patients with PWS. The gene discussed is GH1; the disease is Prader-Willi syndrome.